Tag Archives: IP

BioGen Updates Its Spinoff Plans

By |
3 Comments

BioGen (BIIB) has finally chosen a name for its upcoming hemophilia drug focused spinoff. The new company will be called Bioverativ and it will eventually trade on the Nasdaq under the ticker ‘BIVV’. Bioverativ will be a global biotech company ‘focused on the discovery, research, development and commercialization of treatments for hemophilia and other blood disorders.’ It’s growing… Read More »

Index Change Roundup: Little Movement With Rayonier & Rayonier Advanced Materials, Timken & TimkenSteel, International Paper & Veritiv

By |
0 Comment

The end of June is shaping up to be another busy period in the spinoff world. That means S&P has also been very busy rejiggering its indexes in order to accommodate the new companies. Here is a roundup of the recent activity: 1) Rayonier (RYN) completed the spinoff of its advanced materials company, Rayonier Advanced Materials, on Friday.… Read More »